Canaan Inc. engages in the research, design, and sale of integrated circuit (“IC”) final system products by integrating IC products for bitcoin mining and related components primarily in the PRC.
Recent Security Class Actions
Champignon Brands Inc. purports to be engaged in the formulation and manufacturing of novel ketamine, ketamine derivatives and other psychedelics, and delivery platforms for nutraceutical and psychedelic medicine while being supported by its psychedelic medicine clinic platform.
Amdocs Limited, through its global subsidiaries, provides software and services to communications, cable and satellite, entertainment, and media industry service providers worldwide. Historically, the Company’s largest percentage of revenues come from its North American business, mostly the U.S., particularly from large customers including, among others, AT&T Inc.
3D Systems Corp. provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on demand manufacturing services, and digital design tools.
According to the Complaint, MoneyGram International, Inc., together with its subsidiaries, is a money transfer company that allows customers to send money around the globe.
FLIR Systems, Inc. is a world-leading industrial technology company focused on intelligent sensing solutions for defense and industrial applications.
Ebang International Holdings Inc. purports to be a leading ASIC chip design company and a leading manufacturer of Bitcoin mining machines.
Cubic Corporation is a technology-driven, marketleading provider of integrated solutions that increase situational understanding for transportation, defense command, control, communications, computers, intelligence, surveillance, and reconnaissance (“C4ISR”), and training customers worldwide to decrease urban congestion and improve the militaries’ effectiveness and operational readiness.
Kadmon Holdings, Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The Company’s lead product candidates include, among others, belumosudil (KD025), an orally administered selective inhibitor of ROCK2, which is in Phase II clinical development for the treatment of cGVHD.
Canoo Inc. (formerly known as Hennessy Capital Acquisition Corp. IV) was formed for the purpose of effecting a business combination with specific focus on businesses in the industrial, technology and infrastructure sectors. Such companies are referred to as “blank check” companies or special purpose acquisition companies (“SPACs”). In December 2020, the Company entered into a business combination with Canoo Holdings Limited. The combined company purports to be a mobility technology company that develops electric vehicles.
